Jabil (JBL) closed the most recent trading day at $167.32, moving +0.48% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.03%. Meanwhile, the Dow gained 0.28%, and ...

Shares of Jabil Inc. (NYSE:JBL – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. Two investment ...

Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.

abrdn plc lessened its stake in Jabil Inc. (NYSE:JBL – Free Report) by 10.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).

Jabil (JBL) closed the most recent trading day at $163.62, moving +1.11% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.39%. Meanwhile, the Dow experienced a ...

The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

In a regulatory filing, Jabil (JBL) director Christopher Holland disclosed the sale of 3,400 common shares of the company on January 31 at a ...

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to announce this acquisition. With our shared commitment to creating the best ...